About
GenoCAD provides industrial research operations with an integrated computer-aided design environment for developing complex genetic constructs in the field of synthetic biology. As the manufacturing of synthetic DNA sequences becomes faster and cheaper, GenoCAD unleashes the potential of this new technology by allowing industrial R&D teams to capitalize on their domain expertise to reduce their R&D costs, accelerate their R&D cycle, secure critical intellectual property, and reduce their time to market. Development of synthetic biology today can be likened to development of the semi-conductor industry in the 1970’s. Our business has a potential of $100m in revenues within 5 years and multiples for exits have been in 8x to 28x range in recent years for businesses similarly involved in synthetic biology or bioinformatics.